BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6942718)

  • 1. A comprehensive occupational carcinogen policy as a framework for regulatory activity.
    Ruttenberg R; Bingham E
    Ann N Y Acad Sci; 1981; 363():13-20. PubMed ID: 6942718
    [No Abstract]   [Full Text] [Related]  

  • 2. Deficiencies of science and policy in generic cancer regulation by the Occupational Safety and Health Administration.
    Hoerger FD; Conder JW
    Ann N Y Acad Sci; 1981; 363():21-7. PubMed ID: 6942723
    [No Abstract]   [Full Text] [Related]  

  • 3. Carcinogenic risk management in the United States.
    Selikoff IJ
    Ann N Y Acad Sci; 1981; 363():283-93. PubMed ID: 6942729
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk assessment: too complex, too soon.
    Robbins A
    Ann N Y Acad Sci; 1981; 363():59-61. PubMed ID: 6942735
    [No Abstract]   [Full Text] [Related]  

  • 5. Agencies in dispute over cancer policy.
    Sun M
    Science; 1982 Jul; 217(4556):233. PubMed ID: 7089559
    [No Abstract]   [Full Text] [Related]  

  • 6. Measures for the prevention of occupational cancer.
    Weaver NK
    J Occup Med; 1976 Sep; 18(9):607-10. PubMed ID: 966092
    [No Abstract]   [Full Text] [Related]  

  • 7. OSHA announces proposed cancer policy..
    Am Ind Hyg Assoc J; 1977 Apr; 38(4):A24-9. PubMed ID: 868752
    [No Abstract]   [Full Text] [Related]  

  • 8. The emerging regulatory dilemma.
    Barnard RC
    Ann N Y Acad Sci; 1981; 363():89-98. PubMed ID: 6942737
    [No Abstract]   [Full Text] [Related]  

  • 9. The carcinogen standard of the new Occupational Safety and Health Act.
    Eckardt RE
    Bull N Y Acad Med; 1974 May; 50(5):620-5. PubMed ID: 4522774
    [No Abstract]   [Full Text] [Related]  

  • 10. Why the delay in cancer-protection standards?
    Rose V
    Occup Health Saf; 1977; 46(3):49-50. PubMed ID: 194192
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulators loosen up on carcinogen standards.
    Dickson D
    Nature; 1980 Jan; 283(5745):320-1. PubMed ID: 7352007
    [No Abstract]   [Full Text] [Related]  

  • 12. The renewed dialogue between science and labor.
    Clayman J
    Prev Med; 1972 Aug; 1(3):382-7. PubMed ID: 5085005
    [No Abstract]   [Full Text] [Related]  

  • 13. Occupational cancer risk management in Sweden.
    Holmberg B
    Ann N Y Acad Sci; 1981; 363():255-60. PubMed ID: 6942727
    [No Abstract]   [Full Text] [Related]  

  • 14. Yearly report on carcinogens could be a potent weapon in the war on cancer.
    Carter LJ
    Science; 1979 Feb; 203(4380):525-8. PubMed ID: 760203
    [No Abstract]   [Full Text] [Related]  

  • 15. Anatomy of unreasonable risk.
    Jaeschke WC
    Ann N Y Acad Sci; 1981; 363():49-57. PubMed ID: 6942734
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of assessed risk for carcinogens in Canada: the interplay of social, political, and scientific factors.
    Atherley GR
    Ann N Y Acad Sci; 1981; 363():261-7. PubMed ID: 6942728
    [No Abstract]   [Full Text] [Related]  

  • 17. An alternative to risk-benefit analysis in government decision-making about chemical carcinogens.
    Roderick H
    Ann N Y Acad Sci; 1981; 363():233-45. PubMed ID: 6942725
    [No Abstract]   [Full Text] [Related]  

  • 18. Formaldehyde: a question of cancer policy?
    Perera F; Petito C
    Science; 1982 Jun; 216(4552):1285-91. PubMed ID: 7079759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Existing legislation and government regulatory agencies.
    Quarles JR
    Bull N Y Acad Med; 1978 Apr; 54(4):442-3. PubMed ID: 274979
    [No Abstract]   [Full Text] [Related]  

  • 20. Industrial views and concerns with regard to regulatory process.
    Smith CW
    Tex Rep Biol Med; 1978; 37():204-11. PubMed ID: 752981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.